Impact of switching therapy of prasugrel to clopidogrelon platlet reaction in patients with acute coronary syndrome .

Impact of switching therapy of prasugrel to clopidogrelon platlet reaction in patients with acute coronary syndrome . - Impact of switching therapy of prasugrel to clopidogrel in patients with acute coronary syndrome .

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014283

Enrollment

Registered

2014-06-20

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

prasugrel and clopidogrel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with acute coronary syndrome who underwent stent implantation

Exclusion criteria

Exclusion criteria: Previous warfarin or thienopyridine use. Recent bleeding history. Hematological criteria. Renal insuffiency.

Design outcomes

Primary

Measure	Time frame
P2Y12-reaction-units (PRU) assessed by VerifyNow assay.	—

Countries

Japan

Contacts

Public ContactSoichiro Ebisawa

Shinshu Uniersity Hospital Department of Cardiovascular Medicine

ebifender@yahoo.co.jp0263-37-3352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026